Castle Biosciences, Inc.CSTLNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$8.67M
↑ 137% above average
Average (7y)
$-23.27M
Historical baseline
Range
High:$8.67M
Low:$-72.86M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $8.67M | +112.8% |
| 2023 | $-67.98M | +6.7% |
| 2022 | $-72.86M | -81.8% |
| 2021 | $-40.08M | -512.6% |
| 2020 | $-6.54M | -189.3% |
| 2019 | $7.33M | +291.1% |
| 2018 | $-3.84M | +64.8% |
| 2017 | $-10.90M | - |